Immunological Aspects in Late Phase of Living Donor Liver Transplant Patients: Usefulness of Monitoring Peripheral Blood CD4+ Adenosine Triphosphate Activity

Figure 1

(a) Relationship between the blood concentration of tacrolimus and dosage of tacrolimus after LDLT (𝑅=0.0806,𝑃=0.1162). (b) Relationship between blood concentration of tacrolimus and ImmuKnow ATP level after LDLT (𝑅=0.1473,𝑃=0.2745).

(a)

(b)